Sponsor:
Vanderbilt University Medical Center
Code:
NCT05288790
Conditions
Microtia
Dysbiosis
Alcohol Drinking
HIV Infections
Cardiovascular Diseases
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Probiotic
Placebo
Brief summary:
Conditions
Microtia
Dysbiosis
Alcohol Drinking
HIV Infections
Cardiovascular Diseases
Study ID
NCT05288790
Start date
Sep 18, 2023
Status verified date
Aug, 2026
Completion date
Aug 31, 2027
Anticipated
Primary completion date
Mar 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
250 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Study Supplement
placebo comparator: Study placebo
Interventions
Probiotic
Placebo
Primary outcome measure
Central contacts
Locations
Vanderbilt University Medical Center
Recruiting
Nashville, Tennessee, United States, 37232
Contacts
David Crenshaw, MSW
615-322-7343Sponsor
Vanderbilt University Medical Center
Last update posted
Aug 27, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2026-08-27.